Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family

被引:221
作者
Garlanda, C
Riva, F
Polentarutti, N
Buracchi, C
Sironi, M
De Bortoli, M
Muzio, M
Bergottini, R
Scanziani, E
Vecchi, A
Hirsch, E
Mantovani, A
机构
[1] Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, I-20157 Milan, Italy
[2] Univ Milan, Inst Gen Pathol, Ctr Eccellenza Innovaz Diagnost & Terapeut, I-20133 Milan, Italy
[3] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy
[4] Pharmacia Corp, Dept Pharmacol, I-20014 Nerviano, Italy
[5] Univ Milan, Fac Vet Med, Dept Anim Pathol, I-20133 Milan, Italy
关键词
D O I
10.1073/pnas.0308680101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
also known as single Ig IL-1-related receptor, is a member of the IL-1 receptor/Toll-like receptor (TLR) superfamily, which acts as an intracellular decoy for components of the signaling pathway. Here we report that Tir8 has a unique pattern of expression, which includes mucosal tissues and dendritic cells (DC). Tir8-deficient DC showed increased cytokine production in response to TLR agonists (lipopolysaccharide, CpG oligodeoxynucleotides). Tir8-deficient mice had normal susceptibility to systemic lipopolysaccharide toxicity and to i.p. or s.c. inflammation. However, Tir8-deficient mice were more susceptible to intestinal inflammation. Thus, TIR8 represents a negative pathway of regulation of the IL-1 receptor/TLR system, expressed in epithelial cells and DC, crucial for tuning inflammation in the gastrointestinal tract.
引用
收藏
页码:3522 / 3526
页数:5
相关论文
共 29 条
  • [1] Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice
    Arai, Y
    Takanashi, H
    Kitagawa, H
    Okayasu, I
    [J]. CYTOKINE, 1998, 10 (11) : 890 - 896
  • [2] Inflammatory bowel disease: new insights into pathogenesis and treatment
    Ardizzone, S
    Porro, GB
    [J]. JOURNAL OF INTERNAL MEDICINE, 2002, 252 (06) : 475 - 496
  • [3] The immunological and genetic basis of inflammatory bowel disease
    Bouma, G
    Strober, W
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) : 521 - 533
  • [4] Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4
    Burns, K
    Janssens, S
    Brissoni, B
    Olivos, N
    Beyaert, R
    Tschopp, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) : 263 - 268
  • [5] THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1
    COLOTTA, F
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    [J]. IMMUNOLOGY TODAY, 1994, 15 (12): : 562 - 566
  • [6] Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385
  • [7] The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1
    Dinarello, CA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10) : 732 - 734
  • [8] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147
  • [9] Macrophage migration inhibitory factor and innate immune responses to bacterial infections
    Froidevaux, C
    Roger, T
    Martin, C
    Glauser, MP
    Calandra, T
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : S13 - S15
  • [10] Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response
    Garlanda, C
    Hirsch, E
    Bozza, S
    Salustri, A
    De Acetis, M
    Nota, R
    Maccagno, A
    Riva, F
    Bottazzi, B
    Peri, G
    Doni, A
    Vago, L
    Botto, M
    De Santis, R
    Carminati, P
    Siracusa, G
    Altruda, F
    Vecchi, A
    Romani, L
    Mantovani, A
    [J]. NATURE, 2002, 420 (6912) : 182 - 186